QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as …
Over the last 12 months, insiders at QuidelOrtho Corporation have bought $99,663 and sold $155.18M worth of QuidelOrtho Corporation stock.
On average, over the past 5 years, insiders at QuidelOrtho Corporation have bought $2.41M and sold $48.54M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Busky Joseph M (Chief Financial Officer) — $99,663.
The last purchase of 2,150 shares for transaction amount of $99,663 was made by Busky Joseph M (Chief Financial Officer) on 2024‑02‑23.
2024-08-09 | Sale | 10 percent owner | 74,134 0.11% | $41.53 | $3.08M | +4.18% | ||
2024-08-08 | Sale | 10 percent owner | 106,705 0.1577% | $41.07 | $4.38M | +4.73% | ||
2024-08-07 | Sale | 10 percent owner | 78,180 0.1173% | $39.94 | $3.12M | +9.52% | ||
2024-08-06 | Sale | 10 percent owner | 86,972 0.1299% | $40.23 | $3.5M | +7.74% | ||
2024-08-05 | Sale | 10 percent owner | 118,172 0.1748% | $40.37 | $4.77M | +5.86% | ||
2024-08-02 | Sale | 10 percent owner | 169,467 0.2536% | $42.10 | $7.13M | +2.02% | ||
2024-08-01 | Sale | 10 percent owner | 234,935 0.3468% | $41.52 | $9.75M | +1.76% | ||
2024-07-31 | Sale | 10 percent owner | 164,877 0.242% | $39.11 | $6.45M | +7.40% | ||
2024-07-30 | Sale | 10 percent owner | 150,590 0.2247% | $39.74 | $5.99M | +5.68% | ||
2024-07-29 | Sale | 10 percent owner | 158,090 0.2356% | $38.85 | $6.14M | +9.16% | ||
2024-07-26 | Sale | 10 percent owner | 103,926 0.1557% | $39.05 | $4.06M | +8.58% | ||
2024-07-25 | Sale | 10 percent owner | 406,809 0.6129% | $38.59 | $15.7M | +10.37% | ||
2024-07-24 | Sale | 10 percent owner | 214,732 0.3254% | $38.97 | $8.37M | 0.00% | ||
2024-07-23 | Sale | 10 percent owner | 99,545 0.147% | $36.52 | $3.64M | +5.14% | ||
2024-07-22 | Sale | 10 percent owner | 135,241 0.2016% | $35.31 | $4.78M | +19.16% | ||
2024-07-19 | Sale | 10 percent owner | 65,636 0.0964% | $34.12 | $2.24M | +21.32% | ||
2024-07-18 | Sale | 10 percent owner | 101,870 0.1564% | $34.13 | $3.48M | +26.54% | ||
2024-07-17 | Sale | 10 percent owner | 69,637 0.1038% | $34.81 | $2.42M | +20.53% | ||
2024-07-16 | Sale | 10 percent owner | 94,861 0.1391% | $33.16 | $3.15M | +22.99% | ||
2024-07-15 | Sale | 10 percent owner | 93,187 0.1307% | $31.70 | $2.95M | 0.00% |
Busky Joseph M | Chief Financial Officer | 2150 0.0032% | $37.57 | 1 | 0 | |
SCHULER JACK W | 3414053 5.0762% | $37.57 | 16 | 7 | +11.81% | |
BRYANT DOUGLAS C | President & CEO | 495807 0.7372% | $37.57 | 17 | 77 | +4.66% |
Strobeck Matthew | director | 38145 0.0567% | $37.57 | 2 | 0 | <0.0001% |
TAMERIUS JOHN | SVP, Strat & Ext Affairs | 23540 0.035% | $37.57 | 1 | 16 | +19.46% |
The Carlyle Group | $597.34M | 18.61 | 12.46M | 0% | +$0 | 25.63 | |
T Rowe Price Investment Management Inc | $464.98M | 14.48 | 9.7M | +11.51% | +$47.99M | 0.29 | |
The Vanguard Group | $233.91M | 7.29 | 4.88M | +0.78% | +$1.81M | <0.01 | |
BlackRock | $233.23M | 7.26 | 4.87M | +1.39% | +$3.2M | 0.01 | |
Helm Capital Management LLC | $115.06M | 3.58 | 2.4M | +144.88% | +$68.07M | 3.4 |